Denali Capital Acquisition Corp. announces separate trading of Class A shares and warrants starting May 31, 2022

Semnur Pharmaceuticals, Inc.

Units from IPO of 8,250,000 units may be separated into Class A ordinary shares and warrants effective May 31, 2022.
Each unit consists of one Class A ordinary share and one redeemable warrant to purchase one Class A share at $11.50.
Separated shares trade under DECA and warrants under DECAW; units remain under DECAU on Nasdaq.
No fractional warrants will be issued; holders must contact transfer agent VStock Transfer to separate units.
Joint book-runners were US Tiger Securities, Inc. and EF Hutton; Craig-Hallum acted as qualified independent underwriter.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.